Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
[Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)].
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(7):56-65. doi: 10.17116/jnevro202212207156.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022.
PMID: 35904293
Clinical Trial.
Russian.
[Hypovolemic hyponatremia at the onset of severe ischemic stroke as a predictor of adverse outcome].
Ershov VI, Chirkov AN.
Ershov VI, et al. Among authors: chirkov an.
Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6):10-13. doi: 10.17116/jnevro20161166110-13.
Zh Nevrol Psikhiatr Im S S Korsakova. 2016.
PMID: 27456897
Russian.
Item in Clipboard
[Algorithms of the correction of fluid and electrolyte disorders in patients with severe ischemic stroke].
Ershov VI, Chirkov AN.
Ershov VI, et al. Among authors: chirkov an.
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3. Vyp. 2):31-34. doi: 10.17116/jnevro20171173231-34.
Zh Nevrol Psikhiatr Im S S Korsakova. 2017.
PMID: 28665367
Russian.
Item in Clipboard
[Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].
Soldatov MA, Marskaya NA, Barsegova KA, Androfagina OV, Borisov DN, Karpov DY, Kishinevsky MV, Kucheryavaya MV, Tabakman SV, Telyatnik YA, Fadeeva AS, Khan DS, Chirkov AN, Shamalov NA.
Soldatov MA, et al. Among authors: chirkov an.
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(3. Vyp. 2):33-37. doi: 10.17116/jnevro202112103133.
Zh Nevrol Psikhiatr Im S S Korsakova. 2021.
PMID: 33908230
Russian.
Item in Clipboard
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
Gusev EI, Martynov MY, Nikonov AA, Shamalov NA, Semenov MP, Gerasimets EA, Yarovaya EB, Semenov AM, Archakov AI, Markin SS; FRIDA Study Group.
Gusev EI, et al.
Lancet Neurol. 2021 Sep;20(9):721-728. doi: 10.1016/S1474-4422(21)00210-6.
Lancet Neurol. 2021.
PMID: 34418399
Clinical Trial.
Item in Clipboard
[Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study].
Soldatov MA, Klimov LV, Tolmachev AP, Kiseleva TV, Androfagina OV, Beketova EM, Belkina SN, Borisov DN, Karpov DY, Krasyuk MS, Kucheryavaya MV, Minina YD, Novikov DG, Rogozhnikova NV, Tabakman SV, Teliatnik YA, Tretyakov KV, Fadeeva AS, Khan DS, Chirkov AN, Marskaya NA, Shamalov NA.
Soldatov MA, et al. Among authors: chirkov an.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(12. Vyp. 2):42-49. doi: 10.17116/jnevro202212212242.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022.
PMID: 36582160
Russian.
Item in Clipboard
PROGNOSTIC SIGNIFICANCE OF WATER AND ELECTROLYTE DISORDERS IN THE ACUTE PERIOD OF SEVERE ISCHEMIC STROKE.
Chirkov AN, Ershov VI.
Chirkov AN, et al.
Anesteziol Reanimatol. 2016 Nov;61(6):404-407.
Anesteziol Reanimatol. 2016.
PMID: 29894605
Item in Clipboard
Cite
Cite